Singapore Institute of Advanced Medicine falls 17.4% below IPO price in Catalist debut
SHARES of cancer-treatment provider Singapore Institute of Advanced Medicine (SAM) closed below their initial public offering (IPO) price at the ...
SHARES of cancer-treatment provider Singapore Institute of Advanced Medicine (SAM) closed below their initial public offering (IPO) price at the ...
THE following companies saw new developments that may affect trading of their securities on Friday (Feb 16): Singapore Airlines (SIA): ...
Opinions expressed by Entrepreneur contributors are their own. Combining an entrepreneurial background with a medical career can unlock a world ...
Welly hopes to disrupt the OTC meds aisle.WellyThe medicine aisle may be looking different in the coming months. A slew ...
Opinions expressed by Entrepreneur contributors are their own. Whenever we think about natural medical treatment, only one word clicks in ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.